104 related articles for article (PubMed ID: 12593851)
21. Heparin-like molecules regulate the number of epidermal growth factor receptors on vascular smooth muscle cells.
Reilly CF; Fritze LM; Rosenberg RD
J Cell Physiol; 1988 Jul; 136(1):23-32. PubMed ID: 3260902
[TBL] [Abstract][Full Text] [Related]
22. Fucans, sulfated polysaccharides extracted from brown seaweeds, inhibit vascular smooth muscle cell proliferation. I. Comparison with heparin for antiproliferative activity, binding and internalization.
Logeart D; Prigent-Richard S; Jozefonvicz J; Letourneur D
Eur J Cell Biol; 1997 Dec; 74(4):376-84. PubMed ID: 9438134
[TBL] [Abstract][Full Text] [Related]
23. Pulmonary artery smooth muscle cells from chronically hypoxic neonatal calves retain fetal-like and acquire new growth properties.
Xu Y; Stenmark KR; Das M; Walchak SJ; Ruff LJ; Dempsey EC
Am J Physiol; 1997 Jul; 273(1 Pt 1):L234-45. PubMed ID: 9252561
[TBL] [Abstract][Full Text] [Related]
24. Entry and distribution of fluorescent antiproliferative heparin derivatives into rat vascular smooth muscle cells: comparison between heparin-sensitive and heparin-resistant cultures.
Bârzu T; Pascal M; Maman M; Roque C; Lafont F; Rousselet A
J Cell Physiol; 1996 Apr; 167(1):8-21. PubMed ID: 8698843
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of hypoxic pulmonary hypertension by heparins of differing in vitro antiproliferative potency.
Thompson BT; Spence CR; Janssens SP; Joseph PM; Hales CA
Am J Respir Crit Care Med; 1994 Jun; 149(6):1512-7. PubMed ID: 8004307
[TBL] [Abstract][Full Text] [Related]
26. Structural determinants of the capacity of heparin to inhibit the proliferation of vascular smooth muscle cells.
Castellot JJ; Beeler DL; Rosenberg RD; Karnovsky MJ
J Cell Physiol; 1984 Sep; 120(3):315-20. PubMed ID: 6746751
[TBL] [Abstract][Full Text] [Related]
27. Isolation of vascular smooth muscle cell cultures with altered responsiveness to the antiproliferative effect of heparin.
Caleb BL; Hardenbrook M; Cherington V; Castellot JJ
J Cell Physiol; 1996 May; 167(2):185-95. PubMed ID: 8613458
[TBL] [Abstract][Full Text] [Related]
28. Characterization of rat aortic smooth muscle cells resistant to the antiproliferative activity of heparin following long-term heparin treatment.
Bârzu T; Herbert JM; Desmoulière A; Carayon P; Pascal M
J Cell Physiol; 1994 Aug; 160(2):239-48. PubMed ID: 8040184
[TBL] [Abstract][Full Text] [Related]
29. Heparin oligosaccharide sequence and size essential for inhibition of pulmonary artery smooth muscle cell proliferation.
Garg HG; Cindhuchao N; Quinn DA; Hales CA; Thanawiroon C; Capila I; Linhardt RJ
Carbohydr Res; 2002 Nov; 337(21-23):2359-64. PubMed ID: 12433502
[TBL] [Abstract][Full Text] [Related]
30. Cultured endothelial cells produce a heparinlike inhibitor of smooth muscle cell growth.
Castellot JJ; Addonizio ML; Rosenberg R; Karnovsky MJ
J Cell Biol; 1981 Aug; 90(2):372-9. PubMed ID: 7287812
[TBL] [Abstract][Full Text] [Related]
31. Transforming growth factor-beta activity is potentiated by heparin via dissociation of the transforming growth factor-beta/alpha 2-macroglobulin inactive complex.
McCaffrey TA; Falcone DJ; Brayton CF; Agarwal LA; Welt FG; Weksler BB
J Cell Biol; 1989 Jul; 109(1):441-8. PubMed ID: 2473082
[TBL] [Abstract][Full Text] [Related]
32. Heparin selectively inhibits a protein kinase C-dependent mechanism of cell cycle progression in calf aortic smooth muscle cells.
Castellot JJ; Pukac LA; Caleb BL; Wright TC; Karnovsky MJ
J Cell Biol; 1989 Dec; 109(6 Pt 1):3147-55. PubMed ID: 2592420
[TBL] [Abstract][Full Text] [Related]
33. Effect of carboxyl-reduced heparin on the growth inhibition of bovine pulmonary artery smooth muscle cells.
Garg HG; Mrabat H; Yu L; Freeman C; Li B; Zhang F; Linhardt RJ; Hales CA
Carbohydr Res; 2010 Jun; 345(9):1084-7. PubMed ID: 20399420
[TBL] [Abstract][Full Text] [Related]
34. Studies on vascular smooth muscle cells and dermal fibroblasts in collagen matrices. Effects of heparin.
Ehrlich HP; Griswold TR; Rajaratnam JB
Exp Cell Res; 1986 May; 164(1):154-62. PubMed ID: 3956591
[TBL] [Abstract][Full Text] [Related]
35. Heparin regulates smooth muscle S phase entry in the injured rat carotid artery.
Majesky MW; Schwartz SM; Clowes MM; Clowes AW
Circ Res; 1987 Aug; 61(2):296-300. PubMed ID: 3621492
[TBL] [Abstract][Full Text] [Related]
36. Structural determinants of the capacity of heparin to inhibit the proliferation of vascular smooth muscle cells. II. Evidence for a pentasaccharide sequence that contains a 3-O-sulfate group.
Castellot JJ; Choay J; Lormeau JC; Petitou M; Sache E; Karnovsky MJ
J Cell Biol; 1986 May; 102(5):1979-84. PubMed ID: 3700480
[TBL] [Abstract][Full Text] [Related]
37. Laminarin sulfate mimics the effects of heparin on smooth muscle cell proliferation and basic fibroblast growth factor-receptor binding and mitogenic activity.
Miao HQ; Ishai-Michaeli R; Peretz T; Vlodavsky I
J Cell Physiol; 1995 Sep; 164(3):482-90. PubMed ID: 7650058
[TBL] [Abstract][Full Text] [Related]
38. Differential inhibitory effects of antidiabetic drugs on arterial smooth muscle cell proliferation.
Peuler JD; Phare SM; Iannucci AR; Hodorek MJ
Am J Hypertens; 1996 Feb; 9(2):188-92. PubMed ID: 8924270
[TBL] [Abstract][Full Text] [Related]
39. A synthetic heparin-mimicking polyanionic compound binds to the LDL receptor-related protein and inhibits vascular smooth muscle cell proliferation.
Benezra M; Vogel T; Ben-Sasson SA; Panet A; Sehayek E; Al-Haideiri M; Decklbaum RJ; Vlodavsky I
J Cell Biochem; 2001; 81(1):114-27. PubMed ID: 11180402
[TBL] [Abstract][Full Text] [Related]
40. Effect of heparin on vascular smooth muscle cells. II. Specific protein synthesis.
Cochran DL; Castellot JJ; Karnovsky MJ
J Cell Physiol; 1985 Jul; 124(1):29-36. PubMed ID: 2413048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
